KNSA
USDKiniksa Pharmaceuticals International plc Class A Ordinary Shares
实时价格
价格图表
关键指标
市场指标
开盘价
$39.080
最高价
$39.220
最低价
$38.570
成交量
0.35M
公司基本面
市值
2.9B
所属行业
Drug Manufacturers - Specialty & Generic
国家/地区
United Kingdom
交易统计
平均成交量
0.46M
交易所
NMS
货币
USD
52周价格范围
相关新闻
Goldman Sachs Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $55
Goldman Sachs analyst Paul Choi maintains Kiniksa Pharmaceuticals with a Buy and raises the price target from $45 to $55.
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
– ARCALYST® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net product revenue raised to $670 - $675 million –– KPL-387 granted Orphan
Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $44
Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals with a Outperform and raises the price target from $38 to $44.
相关股票
LMAT
LeMaitre Vascular Inc.
NKE
Nike Inc.
ENGN
enGene Holdings Inc.
FULTP
Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
JLS
Nuveen Mortgage and Income Fund
保持更新
设置价格提醒，获取AI分析更新和实时市场新闻。